BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PRKCA
,
calcium channel activity
,
Allergy to pollen
,
Neuron
,
Quercetin
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphodiesterase 5 inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Liver Pharmacology and Xenobiotic Response Repertoire
Explore Curated Studies Results
Literature
Most Relevant Literature
PDE5 inhibitors and male reproduction: Is there a place for PDE5 inhibitors in infertility clinics o…
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19.
The Effect of PDE5 Inhibitors on the Male Reproductive Tract.
Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach.
Pyrazolopyrimidinone Based Selective Inhibitors of PDE5 for the Treatment of Erectile Dysfunction.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hy…
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
Efficacy of Phosphodiesterase-type 5 Inhibitors in Patients With Univentricular Congenital Heart Dis…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ